Panagiotis Lyberopoulos
National and Kapodistrian University of Athens
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Panagiotis Lyberopoulos.
European Journal of Clinical Investigation | 2011
Paschalina Giouleka; Georgios Papatheodorou; Panagiotis Lyberopoulos; Anna Karakatsani; Manos Alchanatis; Charis Roussos; Spyros Papiris; Stelios Loukides
Eur J Clin Invest 2010; 41 (1): 30–38
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine | 2013
Likurgos Kolilekas; Effrosyni D. Manali; Katerina Vlami; Panagiotis Lyberopoulos; Christina Triantafillidou; Konstantinos Kagouridis; Katerina Baou; Sotirios Gyftopoulos; Konstantinos Vougas; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
BACKGROUND Recent studies suggest poor sleep quality in patients with idiopathic pulmonary fibrosis (IPF). However, so far, the impact of IPF-related sleep breathing disorders (SBDs) on survival has not been extensively studied. METHODS In a cohort of 31 (24 males) treatment-naïve, newly diagnosed consecutive IPF patients, we prospectively investigated the relationship of SBD parameters such as apnea-hypopnea index (AHI), maximal difference in oxygen saturation between wakefulness and sleep (maxdiff SpO2), and lowest sleep oxygen saturation (lowest SpO2) with clinical (survival, dyspnea, daytime sleepiness), pulmonary function, submaximal (6-min walk test [6MWT]) and maximal exercise variables (cardiopulmonary exercise test [CPET]), and right ventricular systolic pressure (RVSP). RESULTS Sleep oxygen desaturation exceeded significantly that of maximal exercise (p < 0.001). Maxdiff SpO2 was inversely related to survival, DLCO%, and SpO2 after 6MWT, and directly with dyspnea, AHI, and RVSP. The lowest SpO2 was directly related to survival and to functional (TLC%, DLCO%) as well as submaximal and maximal exercise variables (6MWT distance, SpO2 after 6MWT, peak oxygen consumption/kg, SpO2 at peak exercise), while an inverse association with dyspnea score, AHI, and RVSP was observed. CONCLUSIONS Our findings provide evidence that intermittent sleep oxygen desaturation significantly exceeds that of maximal exercise and is associated with survival in IPF patients. Furthermore, they imply the existence of a link between lung damage and apnea events resulting to the induction and severity of intermittent sleep oxygen desaturation that aggravate pulmonary arterial hypertension and influence IPF survival.
BMC Pulmonary Medicine | 2010
Effrosyni D. Manali; Panagiotis Lyberopoulos; Christina Triantafillidou; Likourgos Kolilekas; Christina Sotiropoulou; J. Milic-Emili; Charis Roussos; Spyros Papiris
BackgroundExertional dyspnea is the most prominent and disabling feature in idiopathic pulmonary fibrosis (IPF). The Medical Research Chronic (MRC) chronic dyspnea score as well as physiological measurements obtained during cardiopulmonary exercise testing (CPET) and the 6-minute walk test (6MWT) are shown to provide information on the severity and survival of disease.MethodsWe prospectively recruited IPF patients and examined the relationship between the MRC score and either CPET or 6MWT parameters known to reflect physiologic derangements limiting exercise capacity in IPF patientsResultsTwenty-five patients with IPF were included in the study. Significant correlations were found between the MRC score and the distance (r = -.781, p < 0.001), the SPO2 at the initiation and the end (r = -.542, p = 0.005 and r = -.713, p < 0.001 respectively) and the desaturation index (r = .634, p = 0.001) for the 6MWT; the MRC score and VO2 peak/kg (r = -.731, p < 0.001), SPO2 at peak exercise (r = -. 682, p < 0.001), VE/VCO2 slope (r = .731, p < 0.001), VE/VCO2 at AT (r = .630, p = 0.002) and the Borg scale at peak exercise (r = .50, p = 0.01) for the CPET. In multiple logistic regression analysis, the only variable independently related to the MRC is the distance walked at the 6MWT.ConclusionIn this population of IPF patients a good correlation was found between the MRC chronic dyspnoea score and physiological parameters obtained during maximal and submaximal exercise testing known to reflect ventilatory impairment and exercise limitation as well as disease severity and survival. This finding is described for the first time in the literature in this group of patients as far as we know and could explain why a simple chronic dyspnea score provides reliable prognostic information on IPF.
Pulmonary Medicine | 2013
Christina Triantafillidou; Effrosyni D. Manali; Panagiotis Lyberopoulos; Likourgos Kolilekas; Konstantinos Kagouridis; Sotirios Gyftopoulos; Konstantinos Vougas; Anastasia Kotanidou; Manos Alchanatis; Anna Karakatsani; Spyros Papiris
Background. In IPF, defects in lung mechanics and gas exchange manifest with exercise limitation due to dyspnea, the most prominent and disabling symptom. Aim. To evaluate the role of exercise testing through the 6MWT (6-minute walk test) and CPET (cardiopulmonary exercise testing) in the survival of patients with IPF. Methods. This is a prospective, observational study evaluating in 25 patients the relationship between exercise variables through both the 6MWT and CPET and survival. Results. By the end of the observational period 17 patients were alive (33% mortality). Observation ranged from 9 to 64 months. VE/VCO2 slope (slope of relation between minute ventilation and CO2 production), VO2 peak/kg (peak oxygen consumption/kg), VE/VCO2 ratio at anaerobic threshold, 6MWT distance, desaturation, and DLCO% were significant predictors of survival while VE/VCO2 slope and VO2 peak/kg had the strongest correlation with outcome. The optimal model for mortality risk estimation was VO2 peak/kg + DLCO% combined. Furthermore, VE/VCO2 slope and VO2 peak/kg were correlated with distance and desaturation during the 6MWT. Conclusion. The integration of oxygen consumption and diffusing capacity proved to be a reliable predictor of survival because both variables reflect major underlying physiologic determinants of exercise limitation.
Cytokine | 2007
Ioanna Dimopoulou; Apostolos Armaganidis; Evangelia Douka; Irini Mavrou; C Augustatou; Petros Kopterides; Panagiotis Lyberopoulos; Marinella Tzanela; Stylianos E. Orfanos; Emilia Pelekanou; Georgia Kostopanagiotou; Anastasios Macheras; Evangelos J. Giamarellos-Bourboulis
Intensive Care Medicine | 2007
Ioanna Dimopoulou; Konstantinos Stamoulis; Ioannis Ilias; Marinella Tzanela; Panagiotis Lyberopoulos; Stylianos E. Orfanos; Apostolos Armaganidis; Maria Theodorakopoulou; Stylianos Tsagarakis
Hormones (Greece) | 2007
Ioannis Ilias; Konstantinos Stamoulis; Apostolos Armaganidis; Panagiotis Lyberopoulos; Marinella Tzanela; Stylianos E. Orfanos; Maria Theodorakopoulou; Stylianos Tsagarakis; Ioanna Dimopoulou
Archive | 2007
Ioanna Dimopoulou; Konstantinos Stamoulis; Ioannis Ilias; Marinella Tzanela; Panagiotis Lyberopoulos; Stylianos E. Orfanos; Apostolos Armaganidis; Maria Theodorakopoulou; Stylianos Tsagarakis; P. Lyberopoulos; S. Orfanos; M. Theodorakopoulou
European Respiratory Journal | 2013
Likurgos Kolilekas; Effrosyni D. Manali; Panagiotis Lyberopoulos; Katerina Vlami; Christina Triantafillidou; Konstantinos Kagouridis; Sotirios Gyftopoulos; Konstantinos Vougas; Mina Gaga; Anna Karakatsani; Manos Alchanatis; Spyros Papiris
European Respiratory Journal | 2011
Christina Triantafillidou; Panagiotis Lyberopoulos; Likourgos Kolilekas; Konstantinos Kagouridis; Sotirios Gyftopoulos; Christina Sotiropoulou; Anastasia Kotanidou; Anna Karakatsani; Spyros Papiris